- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.11. | Encision reports Q2 results | 1 | Seeking Alpha | ||
| 15.11. | Encision, Inc.: Encision Reports Second Quarter Fiscal Year 2025 Results | 189 | ACCESSWIRE | BOULDER, CO / ACCESSWIRE / November 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy... ► Artikel lesen | |
| 03.09. | Encision director Robert Fries buys $12,880 of company stock | 1 | Investing.com | ||
| 21.08. | Encision, Inc.: Encision Signs Master Services Agreement with Vicarious Surgical Inc. | 293 | ACCESSWIRE | BOULDER, CO / ACCESSWIRE / August 21, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray energy... ► Artikel lesen | |
| 16.08. | Encision GAAP EPS of $0.00, revenue of $1.63M | 1 | Seeking Alpha | ||
| 16.08. | Encision, Inc.: Encision Reports First Quarter Fiscal Year 2025 Results | 350 | ACCESSWIRE | BOULDER, CO / ACCESSWIRE / August 15, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy... ► Artikel lesen | |
| 15.08. | ENCISION INC - 8-K, Current Report | 1 | SEC Filings | ||
| ENCISION Aktie jetzt für 0€ handeln | |||||
| 15.07. | ENCISION INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 15.07. | ENCISION INC - 8-K, Current Report | - | SEC Filings | ||
| 15.07. | Encision GAAP EPS of -$0.03, revenue of $1.53M | 1 | Seeking Alpha | ||
| 15.07. | Encision, Inc.: Encision Reports Fourth Quarter Fiscal Year 2024 Results | 228 | ACCESSWIRE | BOULDER, CO / ACCESSWIRE / July 15, 2024 / Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns... ► Artikel lesen | |
| 01.07. | ENCISION INC - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 14.02. | Encision, Inc.: Encision Reports Third Quarter Fiscal Year 2024 Results | 290 | ACCESSWIRE | BOULDER, CO / ACCESSWIRE / February 14, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| LIFEMD | 5,040 | +3,07 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| TEMPUS AI | 35,500 | +7,48 % | Tempus AI's (TEM) AI-Powered Healthcare Revolution: What's Next? | ||
| FRESENIUS | 33,000 | -0,60 % | Fresenius SE Aktie: Positiver Umsatztrend! | Die Fresenius SE-Aktie zeigt sich im aktuellen Handelsverlauf an der XETRA mit wechselhafter Tendenz. Nach einem Handelsstart bei 34,92 EUR bewegte sich der Kurs im Tagesverlauf zwischen verschiedenen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 17,260 | +1,29 % | BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 14,350 | +1,13 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| GERRESHEIMER | 69,40 | +2,59 % | EQS-News: Gerresheimer AG: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU* | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Zulassungsantrag
Gerresheimer: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU*
16.12.2024 / 09:00... ► Artikel lesen | |
| RXSIGHT | 33,650 | -11,89 % | RxSight cut to hold at Stifel on competition concerns | ||
| PROCEPT BIOROBOTICS | 81,25 | +0,58 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ADAPTHEALTH | 10,305 | +6,40 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| GENEDX | 77,33 | +2,51 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,000 | +0,27 % | Hebel-Idee: DAX-Aufsteiger Fresenius Medical Care: Ausbruch aus dem Abwärtstrend! | © Foto: Wolfgang Filser - picture alliance / SZ PhotoDie Aktie von Fresenius Medical Care wird wieder in den DAX aufgenommen, doch das ist für Anleger nicht die einzige gute Nachricht!Das Börsenjahr... ► Artikel lesen | |
| NANO-X IMAGING | 6,770 | +3,04 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,545 | +5,75 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain | Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 10,610 | +3,21 % | Alignment Healthcare Reports Third Quarter 2024 Results | Reports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end... ► Artikel lesen | |
| M1 KLINIKEN | 15,750 | 0,00 % | Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: M1 Kliniken AG - from First Berlin Equity Research GmbH 17.12.2024 / 12:00 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer... ► Artikel lesen |
Das Unternehmen ENCISION INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENCISION INC finden Sie auf Wallstreet Online.
